CLDX
Celldex Therapeutics Inc.
Halal Rating :
Last Price
$23.80
Last updated:
Market Cap
-
7D Change
-2.14%
1 Year Change
-40.44%
Company Overview
Industries
Exchange
Next Earnings Date
Celldex Therapeutics, Inc. is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. The company's primary focus is on developing treatments for inflammatory, autoimmune diseases and various forms of cancer. Their pipeline includes several candidates targeting rare diseases and oncology indications.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $3.19m | $55.32m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $2.5m | $48.81m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $156000.0 | $40.76m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Celldex Therapeutics Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.